Word: premiums
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...Gillette, the razor-blade maker. Probably more important, though, was the ! fast $34 million that Revlon earned by promising to back off. Investors branded the payoff as a clear case of greenmail, since Gillette agreed to buy back Perelman's 13.9% stake in the company at a premium price that was unavailable to other shareholders...
Some of the worst productions (as well as some of the best) are served up by graduates of the Dramatic Arts courses. Their effect, is, I think, minimal. Technical expertise is at a premium, as any fool can pretend to act but very few can design a light plot. The ART and the unsung hero of Harvard theater, the Loeb's Don Soule, have made an effort to educate fledgling dramatists and designers in the basics, but we must admit that for training we should have gone to Yale or Carnegie-Mellon and press on without...
...example, Fort Worth's Sid Bass and his brothers bought and sold 9.9% of Texaco's shares for a swift profit of $300 million. Manhattan Financier Saul Steinberg earned $60 million that year by buying 11.1% of Walt Disney Productions and then reselling it to the company at a premium, a practice known as greenmail. Boesky made much of his fortune by guessing -- and sometimes knowing -- where the corporate raiders would strike next. Says an eminent Washington securities lawyer: "The millions and millions that are made out of nonproductive deal making represent the collapse of real morality in our markets...
...infinitely cheaper to offer health care insurance on a group basis than on an individual basis, which would have prohibitive premium costs," said Claire Sheahan, spokesman for TIAACREF, the New York-based insurance company that provides pension systems for universities nationwide. Individual coverage could cost hundreds of dollars each year, compared to an employer provided plan that would run only a few dollars a month, said Sheahan...
...developer and manufacturer of the drug, Ophthalmologist Alan Scott, lost his liability insurance last year. In January, unable to find another insurer willing to charge a reasonable premium, he notified doctors who were participating in the Oculinum trials that without coverage he would no longer be able to supply the drug. Because people associate the drug with botulism, ! Scott told the New York Times, insurers are afraid they will be hit with huge damage suits if any untoward side effects occur. He notes that among some 7,000 patients who have received the drug to date, side effects have been...